Loading insider details...
Latest Form 4 (Jun 11, 2026): Grant/Award of 33,350 IMRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Immuneering Corp (IMRX) | Grant/Award | 33,350 | n/a |
| Jul 7, 2025 | Immuneering Corp (IMRX) | Purchase | 2,500 | $9.0K |
| Jun 16, 2025 | Immuneering Corp (IMRX) | Grant/Award | 33,350 | n/a |
| Jun 13, 2024 | Immuneering Corp (IMRX) | Grant/Award | 33,350 | n/a |
| May 9, 2024 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Sale | 3,356 | $42.4K |
| Feb 6, 2024 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Grant/Award | 337,500 | n/a |
| Jun 15, 2023 | Immuneering Corp (IMRX) | Grant/Award | 17,500 | n/a |
| May 10, 2023 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Grant/Award | 39,732 | n/a |
| Jun 23, 2022 | Immuneering Corp (IMRX) | Grant/Award | 6,185 | n/a |
| Jan 18, 2022 | Immuneering Corp (IMRX) | Grant/Award | 25,200 | $327.6K |